HSHHSH Health Technology Supplier Hub
Home › Suppliers › Wolters Kluwer Health › Risk

Wolters Kluwer Health: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Parent Wolters Kluwer (WKL.AS) group FY2025 revenue €6.12bn (+3.5%); operating margin 28.3%; net income €1.31bn.

Health division revenue €1.60bn (+5% organic); net debt €4.02bn.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Wolters Kluwer Health found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Wolters Kluwer Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Clinical decision support and drug information supplier; no regulatory or clinical safety actions involving Wolters Kluwer Health found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Dec 2025: Barking, Havering and Redbridge University Hospitals NHS Trust selected UpToDate Enterprise Edition. Jul 2025: Royal Devon University Healthcare NHS Foundation Trust also selected it.

Researched 10 Nov 2026